相关实验视频

Updated: May 6, 2026

An In Vitro Approach to Photodynamic Therapy

An In Vitro Approach to Photodynamic Therapy

Published on: August 17, 2018

皮肤光动力学疗法的分子生物标志物:综合性审查

Jorge Naharro-Rodriguez^1,2, Stefano Bacci³, Montserrat Fernandez-Guarino²

¹Programa de Doctorado en Ciencias de la Salud, Universidad de Alcalá de Henares, 28801 Madrid, Spain.

Diagnostics (Basel, Switzerland)

|December 17, 2024

概括

光动力疗法 (PDT) 降低了皮肤疾病中的p53和Ki-67等关键生物标志物,促进了细胞亡和原蛋白的产生,以获得更好的治疗. 这促进了皮肤的复发和伤口愈合.

科学领域:

皮肤病学皮肤病学
生物化学生物化学
分子生物学分子生物学

背景情况:

光动力疗法 (PDT) 是一种常见的皮肤治疗方法.
精确的分子机制和PDT的生物标志物尚未完全理解.
了解这些变化对于优化PDT协议至关重要.

研究的目的:

探索与PDT相关的分子生物标志物.
评估PDT的潜在机制.
为个性化PDT治疗策略提供信息.

主要方法:

进行了叙事文学评论.
在PubMed,Scopus和Web of Science数据库中进行了搜索.
包括PDT和生物标志物的原始研究,评论和元分析.

主要成果:

PDT降低了p53,Cyclin D1和Ki-67等生物标志物,减少了癌症病变的增殖和增加了癌症病变的亡.
PDT刺激了原蛋白的产生和细胞外矩阵的重塑.
这些效应表明皮肤再生和慢性伤口治疗中的作用.

结论:

通过向增殖和亡途径,PDT有效治疗皮肤病.
进一步的研究可以优化PDT参数和组合疗法.
这可以改善患者的治疗结果和个性化皮肤病治疗.

关键词:

生物标志物生物标志物皮肤学皮肤学组织学组织学组织学光动力学疗法是一种光动力学疗法.

更多相关视频

An In-House-Built and Light-Emitting-Diode-Based Photodynamic Therapy Device for Enhancing Verteporfin Cytotoxicity in a 2D Cell Culture Model

An In-House-Built and Light-Emitting-Diode-Based Photodynamic Therapy Device for Enhancing Verteporfin Cytotoxicity in a 2D Cell Culture Model

Published on: January 13, 2023

LED-Based In Vitro Screening for Assessing Photoactivable Molecules in Bacterial Photodynamic Inactivation

LED-Based In Vitro Screening for Assessing Photoactivable Molecules in Bacterial Photodynamic Inactivation

Published on: January 24, 2025

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...